3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 22383427 | Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways. | 2012 Jun | 1 |
| 2 | 18056648 | A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer. | 2008 Apr | 2 |
| 3 | 18040273 | A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV. | 2007 Dec 3 | 1 |